Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avisa Diagnostics Inc. a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement of 1,390,000 common shares of the Company to raise … NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. Avisa Diagnostics Inc. (CSE:AVBT) (“ Avisa ” or the “ Company ”), a clinical-stage medical device company developing an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of virulent bacterial lung infections, today announced that it intends to conduct a non-brokered private placement (the “ Offering ”) of 1,390,000 common shares (“ Common Shares ”) of the Company to raise approximately CAN$375,000 at a price of CAN$0.27 per Common Share.